Research published in Scientific Reports describes a new ultra lightweight system for recording neural activity in the brains of mice.
- (-) Remove Information on drugs and diseases filter Information on drugs and diseases
- (-) Remove Aged filter Aged
- (-) Remove Non-Human Primate filter Non-Human Primate
- (-) Remove Equine filter Equine
- (-) Remove Other Resources filter Other Resources
Discipline tool
MouseAGE is opening a call for European researchers to establish their infrastructure needs in the area of ageing and age-related disorders at the preclinical stage with a view to coordinate efforts for applications for funding.
General Database Information
ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines are intended to improve the reporting of research using animals – maximising information published and minimising unnecessary studies.
The EURL ECVAM DataBase service on ALternative Methods (DB-ALM).
AMC Tool is a programme to calculate antimicrobial consumption. It is aimed to replace the old ABC Calc tool.
The CAMARADES collaboration provides a supporting framework for groups involved in the systematic review and meta-analysis of data from experimental animal studies.
Our interests range from identifying potential sources of bias in animal work; developing recommendations for improvements in the design and reporting of animal studies; developing the meta-analysis methodology the better to apply it to animal studies; through to the selection of candidate stroke drugs for clinical trial.
CAMARADES aims to provide a central focus for data sharing; to act as a resource for those wishing to carry out such reviews; to provide a web based stratified meta-analysis bioinformatics engine (under development!); and to act as a repository for completed reviews.
The International Society for Pharmacoepidemiology (ISPE) is a non-profit international professional membership organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.